Absorption Enhancers for Nasal Drug Delivery
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 42 (13) , 1107-1128
- https://doi.org/10.2165/00003088-200342130-00003
Abstract
This paper describes the basic concepts for the transmucosal delivery of drugs, and in particular the use of the nasal route for delivery of challenging drugs such as polar low-molecular-weight drugs...Keywords
This publication has 150 references indexed in Scilit:
- Chitosan-Induced Perturbation of Dipalmitoyl-sn-glycero-3-phosphocholine Membrane BilayerLangmuir, 2001
- Absorption Enhancement of a Protein Drug by Nitric Oxide Donor: Effect on Nasal Absorption of Human Granulocyte Colony-Stimulating FactorJournal of Drug Targeting, 2000
- Toxicological Implications of Nasal FormulationsDrug Delivery, 1999
- Acylated non-α-amino acids as novel agents for the oral delivery of heparin sodium, USPJournal of Controlled Release, 1998
- Permeation of polysucrose 15 000 across the human nasal mucosa in vivoAllergy, 1997
- Safety, Tolerability, and Pharmacokinetics of Sumatriptan in Healthy Subjects Following Ascending Single Intranasal Doses and Multiple Intranasal DosesCephalalgia, 1997
- Mucosal Penetration EnhancementJournal of Drug Targeting, 1995
- Intranasal InsulinClinical Pharmacokinetics, 1992
- Nasal absorption in rats. II. Effect of enhancers on insulin absorption and nasal histologyInternational Journal of Pharmaceutics, 1991
- Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I.Journal of Pharmacobio-Dynamics, 1989